Hend El-sherbini Loses 19.5 Million From Idh Shares

Hend El-Sherbinis IDH stake plunges 19.5 million as stock drops 26 despite company posting record revenue and profit growth in 2024.

IDH reports 39 revenue surge to 111.9 million, driven by more tests and patient visits across its five-country diagnostic network.

Investor confidence wanes as IDH stock falls 22.7 year-to-date, erasing millions in value for shareholders amid emerging market concerns.

Egyptian businesswoman Hend El-Sherbini, one of the country's wealthiest entrepreneurs, has experienced a significant financial setback as the value of her holdings in Integrated Diagnostics Holdings IDH has dropped by over 19 million in recent months. This is attributed to a sustained decline in the companys share price on the London Stock Exchange following its voluntary delisting from the Egyptian Exchange EGX in 2024.

El-Sherbini, who serves as CEO of IDH, is a key figure in the companys rise as a leading diagnostic service provider in the Middle East and North Africa MENA region. Her stake in the company, which amounts to 27.94 percent equivalent to 162,445,383 shares, has now fallen by 19.49 million due to the downturn in IDH's stock price.

IDH is one of the largest consumer healthcare groups in MENA, offering over 3,000 diagnostic tests across its network of 628 laboratories spanning five countries. The company remains Egypts largest diagnostic service provider, with a strong reputation for delivering high-quality healthcare services.

In its most recent financial report, IDH posted a revenue of EGP5.72 billion 111.88 million for fiscal year 2024, marking a 38.73 percent increase from EGP4.12 billion 80.65 million in 2023. The company also reported a net profit of EGP1 billion 19.72 million for FY 2024, reflecting a remarkable 115.38 percent growth from EGP468 million 9.15 million in 2023. The surge in both revenue and profit was driven by a 9 percent year-on-year increase in testing volume and a 5 percent rise in patient visits.

Despite these positive financial results, IDHs stock has taken a significant hit in the past three months. The companys share price on the London Stock Exchange has plunged by 26.09 percent, from 0.46 on Jan. 6 to 0.34 at the time of writing, reducing IDHs market value to 204 million. This decline has impacted major shareholders, including El-Sherbini, whose stake in the company has dropped from 74.72 million to 55.23 million over the period.